Gerresheimer stock holds JPMorgan Buy rating as valuation debate intensifies

Published on 09/11/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock remains rated Buy by JPMorgan as of September 11, 2026, with the shares trading below their one-year high and consensus pointing to more cautious expectations. Recent price and volume data frame the risk-reward profile for investors.

Automatisierte Glasampullen-Produktionslinie in steriler Pharmafabrik — Gerresheimer AG mit ISIN DE000A0LD6E6 produziert Glasampullen in hochautomatisierter, steriler Pharmaverpackungsfertigung mit modernster Anlagentechnik, Illustration mit AI erstellt.

Gerresheimer stock (ISIN DE000A0LD6E6) continues to be rated Buy by JPMorgan as of September 11, 2026, while the shares trade noticeably below their one-year high, underscoring an ongoing valuation debate for investors.

JPMorgan sticks to Buy as consensus turns cautious

According to The Globe and Mail on September 11, 2026, JPMorgan analyst Anchal Verma has reiterated a Buy rating on Gerresheimer, signaling confidence in the company’s medium-term prospects despite recent share price volatility.

The same report notes that the company’s shares previously closed at EUR 29.16, with analyst consensus on Gerresheimer now at Hold and an average price target of EUR 26.13, indicating that JPMorgan’s stance is more optimistic than the broader market view.

As highlighted by The Globe and Mail, Gerresheimer’s one-year trading range extends from a low of EUR 14.83 to a high of EUR 44.76, so the last closing level around EUR 29 is roughly one third below the top of that band and almost double the one-year low, reflecting a mid-range valuation after a period of significant swings.

Share price, range and trading activity frame risk profile

Per the JPMorgan-related overview reported by The Globe and Mail, Gerresheimer’s one-year high of EUR 44.76 stands well above the recent closing price, while the one-year low of EUR 14.83 marks the lower bound of investor risk in the past year.

The same data set shows average daily volume at 194,400 shares, which provides investors with sufficient liquidity for position adjustments without materially impacting the price in normal trading conditions.

For investors, the current positioning between EUR 14.83 and EUR 44.76, together with a Hold consensus and Buy outlier from JPMorgan, suggests a balanced risk-return set-up where upside potential and downside risk are both clearly visible in the numbers.

Stock trades below recent peak on primary venue

On Xetra, which is the primary trading venue for Gerresheimer shares in euros, the stock’s recent closing price around EUR 29 as of early September 2026 places it well below the one-year high of EUR 44.76 but comfortably above the one-year low of EUR 14.83, highlighting a recovery from prior troughs without yet retesting peak levels.